Privacypolicy

   In the field of modern life science research and development, virtual screening technology is rapidly emerging as an important tool for revealing the interactions between biomolecules, accelerating drug development, and advancing basic research. Virtual screening technology, by combining advanced methods from bioinformatics, computational biology, and artificial intelligence, can efficiently and accurately identify potential molecules from massive databases, opening up a new path for biological research and clinical applications.

        Proteins are the core molecules of life activities, and their structure and function directly determine the occurrence and development of many biological processes and diseases. Therefore, studying the interactions between proteins and compounds, as well as between proteins, has important scientific value and clinical significance. Virtual screening technology provides precise analysis methods across scales and dimensions, and has become an important means of solving complex biological problems and developing new research and development strategies.

        This manual comprehensively introduces the innovative products and technical services of Hefei Kejing Biotechnology in the field of virtual screening, including interacting protein screening, potential compound screening, nanobody design and screening, de novo design combined with short peptides, protein targeted modification, etc. We are committed to providing customers with a full process solution from basic research to application development by integrating the latest artificial intelligence algorithms and cutting-edge computing technologies, significantly improving screening efficiency, reducing research and development costs, and accelerating scientific breakthroughs.

        In the future, virtual screening technology will continue to expand its application boundaries in biomedical, agricultural, industrial, and environmental fields. We look forward to working together with research institutions, enterprises, and medical institutions to promote the leapfrog development of life sciences and contribute to human health and social progress.